Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum haptoglobin in patients with ovarian malignancies.

× No keyword cloud information.

14 in total

1. Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis.

Authors: John D Andersen; Kristin L M Boylan; Feifei S Xue; Lorraine B Anderson; Bruce A Witthuhn; Todd W Markowski; Leeann Higgins; Amy P N Skubitz
Journal: Electrophoresis Date: 2010-01 Impact factor: 3.535

2. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis.

Authors: M C Cid; D S Grant; G S Hoffman; R Auerbach; A S Fauci; H K Kleinman
Journal: J Clin Invest Date: 1993-03 Impact factor: 14.808

3. Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.

Authors: Kristin Lm Boylan; John D Andersen; Lorraine B Anderson; LeeAnn Higgins; Amy Pn Skubitz
Journal: Proteome Sci Date: 2010-06-14 Impact factor: 2.480

4. Early diagnosis of ovarian cancer.

Authors: D R Popkin
Journal: Can Med Assoc J Date: 1979-05-05 Impact factor: 8.262

5. Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer.

Authors: R Samak; R Edelstein; L Israel
Journal: Cancer Immunol Immunother Date: 1982 Impact factor: 6.968

6. Prognostic significance of serum alpha 1-acid glycoprotein in patients with glioblastoma multiforme: a preliminary communication.

Authors: H Matsuura; S Nakazawa
Journal: J Neurol Neurosurg Psychiatry Date: 1985-08 Impact factor: 10.154

Serum haptoglobin in patients with ovarian malignancies.

1. Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis.

2. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis.

3. Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.

4. Early diagnosis of ovarian cancer.

5. Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer.

6. Prognostic significance of serum alpha 1-acid glycoprotein in patients with glioblastoma multiforme: a preliminary communication.

7. ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.

8. Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes.

9. Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines.

10. Relationship of total serum sialic acid to sialylglycoprotein acute-phase reactants in malignant melanoma.